2016

Posters

SFPT Avril 2016

  • L. Gaboriau, D. Brasselet, J. Béné, P. Bigot, A. Verier, A.S. Bertheloot, P. Coupé, M. Auffret. Dimethylfumarate induced eosinophilia: report of 2 cases.
  • L. Gaboriau, M. Auffret, J. Béné, H. Cattoir-Vue, S. Gautier. Pruritus: a significant side effect with fampridine.
  • D. Brasselet, M. Auffret, J. Béné, A. Louvet, S. Gautier. Induced-liver injury with drugs other than acetaminophen: a 12-years retrospective study about patients hospitalized in the hepato-gastroenterology care service at the university hospital of Lille.
  • D. Brasselet, S. Gautier, L. Gaboriau, A. Rollin-Sillaire, M. Auffret. Cognitive impairment induced by chemotherapy in young patients with lymphoma and leukemia: about three cases.
  • Auffret M, Gaboriau L, Béné J, Gautier S, Canva V. Multidiscplinary meeting for initiating direct acting antivirals in chronic hepatitis C: the role of clinical pharmacologist. SFPT 2016 (Nancy)
  • Chatelet JN, Auffret M, Gaboriau L, Béné J, Lambert M, Gautier S. Surdité induite par l’hydroxychloroquine : premier cas de ré-introduction positive et revue de la base nationale de pharmacovigilance. SFPT 2016 (Nancy)
  • J Béné, M Wiart, L Gaboriau, MH Dubus, S Gautier. Thrombocytosis during apixaban therapy: first case report. SFPT 2016 (Nancy)
  • J Béné, M Bayen, M Rochoy, L Gaboriau, S Gautier General practitioners and patients’ opinion face to direct oral anticoagulants. SFPT 2016 (Nancy)
  • J Béné, M Bayen, L Gaboriau, M Rochoy, S Gautier. Direct oral anticoagulants prescription patterns: a study among Nord-Pas de Calais general practitioners. SFPT 2016 (Nancy)
  • C Rousselin, J Béné, M Lambert, S Gautier. Non hemorrhagic articular manifestations related to antivitamin K treatment, analyse of pharmacovigilance database. SFPT 2016 (Nancy)
  • M Markarian, P Carlier, N Bernard, L Lagarce, A Dautriche, J Béné, … Pregnancy outcome among partners of male patients receiving imatinib, dasatinib or nilotinib in chronic myeloid leukemia (CML): reports collected by the French regional pharmacovigilance (PV) centers. SFPT 2016 (Nancy)

Hopipharm Mai 2016

  • DELABRE J., LECLERCQ F., BEEKHAREE – BRASSELET D., BÉNÉ J. « Associations médicamenteuses contre-indiquées : quelles alternatives ? »

SFPC 2016

  • Auffret M, Carpentier I, Mutombo M, Silvain J, Kerkani N, Trivier JM, Gautier S, Yilmaz M. Analyse descriptive des erreurs médicamenteuses concernant les antalgiques collectées dans une région française en 2014 – Société Française de Pharmacie Clinique 2016 (Montpellier)
  • Auffret M, Caous AS, Rolland B, Deheul S, Béné J, Gaboriau L, Bordet R, Gautier S. La RTU du baclofène dans l’alcoolodépendance : qu’en est-il pour le pharmacien d’officine ? – Société Française de Pharmacie Clinique 2016 (Montpellier)

Articles

Publications internationales :

  • Levavasseur M, Darras S, Mortier L, Goeminne C, Auffret M, Bertrand M. Drug interaction between dabrafenib and immunosuppressive drugs: about one case. Melanoma Res. 2016 Jul 8. [Epub ahead of print]
  • Bigot P, Auffret M, Gautier S, Weinborn M, Ettahar NK, Coupé P. Unexpected platelets elevation in a patient with idiopathic thrombocytopenia treated with oseltamivir for influenza infection. Fundam Clin Pharmacol. 2016 Jun 25. [Epub ahead of print]
  • Rolland B, Auffret M, Franchitto N. Safety reports on the off-label use of baclofen for alcohol-dependence: recommendations to improve causality assessment. Expert Opin Drug Saf. 2016 Apr 1:1-5.
  • Cottin J, Gouraud A, Jean-Pastor MJ, Dautriche AD, Boulay C, Geniaux H, Auffret M, Bernard N, Descotes J, Vial T. Safety profile of etifoxine: A French pharmacovigilance survey. Fundam Clin Pharmacol. 2016;30(2):147-52.
  • De Boissieu P, Gaboriau L, Morel A, Trenque T. Bisphosphonate-related osteonecrosis of the jaw: data from the French national pharmacovigilance database. Fundam Clin Pharmacol. 2016 Oct;30(5):450-8.
  • Pierson-Marchandise M, Gras V, Moragny J, Micallef J, Gaboriau L, Picard S, Choukroun G, Masmoudi K, Liabeuf S. The drugs that mostly frequently induce acute kidney injury: a case - non-case study of a pharmacovigilance database. Br J Clin Pharmacol. 2016 Dec 21
  • Faure E, Galperine T, Cannesson O, Alain S, Gnemmi V, Goeminne C, Dewilde A, Béné J, Lasri M, Lessore de Sainte Foy C, Lionet A. Case report: Brincidofovir-induced reversible severe acute kidney injury in 2 solid-organ transplant for treatment of cytomegalovirus infection. Medicine (Baltimore). 2016 Nov;95(44):e5226.
  • Béné J, Ley D, Roboubi R, Gottrand F, Gautier S. Eosinophilic esophagitis after desensitization to dust mites with sublingual immunotherapy. Ann Allergy Asthma Immunol. 2016 Jun;116(6):583-4.
  • Béné J, Moulis G, Bennani I, Auffret M, Coupe P, Babai S, Hillaire-Buys D, Micallef J, Gautier S; French Association of Regional PharmacoVigilance Centres. Bullous pemphigoid and dipeptidyl peptidase IV inhibitors: a case-noncase study in the French Pharmacovigilance Database. Br J Dermatol. 2016 Aug;175(2):296-301.

Publications françaises :

  • Gaboriau L, Boursier A, Béné J, Hassinet HR, Gautier S. [Herbal preparations can cause acute hepatitis?].Presse Med. 2016 May;45(5):545-6
  • Caron J, Rochoy M, Gaboriau L, Gautier S. The history of pharmacovigilance. Therapie. 2016 Apr;71(2):129-34
  • Chatelet JN, Auffret M, Combret S, Bondon-Guitton E, Lambert M, Gautier S. Surdité sous hydroxychloroquine : à propos d’un cas de réintroduction positive et analyse de la base française de pharmacovigilance. Rev med int accepté pour publication
  • Rochoy M, Béné J, Messaadi N, Auffret M, Gautier S. [Evaluation of the website of the Nord-Pas-de-Calais regional pharmacovigilance center]. Therapie. 2016 Jun;71(3):329-33. Epub 2016 Feb 11.
  • Carlier P, Bernard N, Lagarce L, Dautriche A, Béné J, Fouilhé Sam-Lai N, Eftekhari P. Pregnancy outcome among partners of male patients receiving imatinib, dasatinib or nilotinib in chronic myeloid leukemia: reports collected by the French network pharmacovigilance centers. Arch Gynecol Obstet. 2016 Dec 10.
  • Ramon M, Tourteau E, Lemaire N, Gautier S, Béné J. HyperCKemia induced by levetiracetam. Presse Med. 2016 Oct;45(10):943-944.
  • Simon C, Agier MS, Béné J, Muller C, Vrignaud L, Marret H, Jonville-Bera AP. [Safety profile of etonogestrel contraceptive implant (Nexplanon® and Implanon®) reported in France]. J Gynecol Obstet Biol Reprod (Paris). 2016 Nov;45(9):1074-1082.